Craig C. Hopkinson - 18 Feb 2022 Form 4 Insider Report for Alkermes plc. (ALKS)

Role: EVP R&D, Chief Medical Officer
Signature: /s/ Stephanie Roche, attorney-in-fact for Craig C. Hopkinson
Issuer symbol: ALKS
Transactions as of: 18 Feb 2022
Net transactions value: -$271,651
Form type: 4
Filing time: 23 Feb 2022, 15:40:33 UTC
Previous filing: 17 Feb 2022
Next filing: 24 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALKS	Ordinary Shares	Sale	$58,042	-2,306	-20%	$25.17	9,496	18 Feb 2022	Direct	F1
transaction	ALKS	Ordinary Shares	Options Exercise		+10,096	+106%		19,592	20 Feb 2022	Direct	F2
transaction	ALKS	Ordinary Shares	Tax liability	$74,387	-2,966	-15%	$25.08	16,626	20 Feb 2022	Direct
transaction	ALKS	Ordinary Shares	Options Exercise		+6,875	+41%		23,501	21 Feb 2022	Direct	F2
transaction	ALKS	Ordinary Shares	Tax liability	$50,712	-2,022	-8.6%	$25.08	21,479	21 Feb 2022	Direct
transaction	ALKS	Ordinary Shares	Options Exercise		+12,037	+56%		33,516	22 Feb 2022	Direct	F2
transaction	ALKS	Ordinary Shares	Tax liability	$88,510	-3,539	-11%	$25.01	29,977	22 Feb 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALKS	Employee Stock Option (Right to Buy)	Award	$0	+139,554		$0.000000	139,554	18 Feb 2022	Ordinary Shares	139,554	$25.08	Direct	F3
transaction	ALKS	Restricted Stock Unit Award	Award	$0	+34,889		$0.000000	34,889	18 Feb 2022	Ordinary Shares	34,889	$0.000000	Direct	F4
transaction	ALKS	Restricted Stock Unit Award	Options Exercise		-10,096	-33%		20,191	20 Feb 2022	Ordinary Shares	10,096	$0.000000	Direct	F2, F5
transaction	ALKS	Restricted Stock Unit Award	Options Exercise		-6,875	-50%		6,875	21 Feb 2022	Ordinary Shares	6,875	$0.000000	Direct	F2, F6
transaction	ALKS	Restricted Stock Unit Award	Options Exercise		-12,037	-25%		36,114	22 Feb 2022	Ordinary Shares	12,037	$0.000000	Direct	F2, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2	Restricted stock units convert into ordinary shares on a one-for-one basis.
F3	Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023.
F4	Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/18/2023.
F5	Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/20/2021.
F6	Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/21/2020.
F7	Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/22/2022.